Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relative Effects of Single Doses of Olmesartan Medoxomil, Irbesartan and Valsartan at High Dosage Levels on the Renin-Angiotensin-Aldosterone System in Healthy Normal Subjects

NCT00185055 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00185055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relative Effects of Single Doses of Olmesartan Medoxomil, Irbesartan and Valsartan at High Dosage Levels on the Renin-Angiotensin-Aldosterone System in Healthy Normal Subjects
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2004
Completion date
February 28, 2005
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy